Sheba Medical Center: Depressive Disorder trials

The registry lists 15 Depressive Disorder studies with Sheba Medical Center as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 5No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Development of a Model for Digital Monitoring of the Mental State of the Hospitalized PatientRecruitingNCT06182787
• Ketamine IV Classic Protocol : Five Years Follow upCompletedNCT04824157
• Early Diagnosis of PPD Through Self-portraitsCompletedNCT03791021
• D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant DepressionStatus unknownNCT02772211Phase 4
• Ketamine Infusions for Major Depression DisorderStatus unknownNCT02219867Not applicable
• Efficacy Study of Escitalopram for Depression in Patients With DiabetesStatus unknownNCT00650897Phase 4
• Screening Questionnaire for DepressionStatus unknownNCT00480233
• Escitalopram and Sleep Architecture in Patients With Major Depressive DisorderStatus unknownNCT00442481Phase 4
• Hormonal Levels in Men With Major Depressive DisorderWithdrawnNCT00429689
• A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Status unknownNCT00335205Phase 4
• The Effectiveness of Idazoxan in Treating TRDWithdrawnNCT00294944Phase 3
• Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression DisorderCompletedNCT00229398
• Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's DementiaStatus unknownNCT00229333Phase 4
• Fibromyalgia in Men Suffering From PTSDCompletedNCT00229294
• A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant DepressionStatus unknownNCT00220480Not applicable